- Home
- TFPM vs MRUS Comparison
TFPM vs MRUS Comparison
Compare TFPM & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFPM
- MRUS
- Stock Information
- Founded
- TFPM 2016
- MRUS 2003
- Country
- TFPM Canada
- MRUS Netherlands
- Employees
- TFPM N/A
- MRUS N/A
- Industry
- TFPM Precious Metals
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- TFPM Industrials
- MRUS Health Care
- Exchange
- TFPM Nasdaq
- MRUS Nasdaq
- Market Cap
- TFPM 4.3B
- MRUS 3.5B
- IPO Year
- TFPM N/A
- MRUS 2016
- Fundamental
- Price
- TFPM $24.70
- MRUS $53.11
- Analyst Decision
- TFPM Strong Buy
- MRUS Strong Buy
- Analyst Count
- TFPM 3
- MRUS 12
- Target Price
- TFPM $23.67
- MRUS $87.92
- AVG Volume (30 Days)
- TFPM 488.8K
- MRUS 2.0M
- Earning Date
- TFPM 08-18-2025
- MRUS 07-31-2025
- Dividend Yield
- TFPM 0.89%
- MRUS N/A
- EPS Growth
- TFPM N/A
- MRUS N/A
- EPS
- TFPM 0.02
- MRUS N/A
- Revenue
- TFPM $293,708,000.00
- MRUS $54,732,000.00
- Revenue This Year
- TFPM $19.66
- MRUS $75.57
- Revenue Next Year
- TFPM $0.85
- MRUS $31.84
- P/E Ratio
- TFPM $993.66
- MRUS N/A
- Revenue Growth
- TFPM 39.01
- MRUS 42.77
- 52 Week Low
- TFPM $13.94
- MRUS $33.19
- 52 Week High
- TFPM $25.45
- MRUS $62.98
- Technical
- Relative Strength Index (RSI)
- TFPM 65.26
- MRUS 53.18
- Support Level
- TFPM $24.26
- MRUS $52.41
- Resistance Level
- TFPM $25.45
- MRUS $54.59
- Average True Range (ATR)
- TFPM 0.66
- MRUS 2.15
- MACD
- TFPM 0.02
- MRUS -0.77
- Stochastic Oscillator
- TFPM 75.33
- MRUS 7.62
About TFPM Triple Flag Precious Metals Corp.
Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.